Sulfamethoxazole, also known as the new promise, is a broad-spectrum antimicrobial agents, Staphylococcus aureus and E. coli particularly strong role in the treatment of urinary tract infections and poultry cholera and so on. Sulfamethoxazole is a systemic application of the effect of sulfonamides, which can compete with PABA bacteria in the body of dihydrofolate synthase, to prevent the synthesis of bacterial dihydrofolate, thereby inhibiting the growth and reproduction of bacteria. And sulfadiazine, sulfonamidoxazole, three sulfonamide three sulfonamides are currently the best drugs for the treatment of nocardiosis.
Appearance White crystalline powder
Assay 99.00% -101.00%
Loss on drying 0.50% Max.
Sulphated ash 0.10% Max.
Heavy metals 20.00ppm Max.
Melting point 169.00ºC-172.00ºC
Related substances by TLC 0.50% Max..
Acidity 0.30ml Max.. of 0.1M NaOH
Use sulfa drugs, mainly for the treatment of acute and chronic urinary tract infection, can also be used for the prevention of meningitis and influenza caused by acute otitis media